WCM
ABBV icon

Winton Capital Management’s AbbVie ABBV Stock Holding History

Winton Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$55.3M Buy
1,076,653
+552,808
+106% +$27.9M 0.38% 80
2013
Q4 		$27.7M Buy
523,845
+476,054
+996% +$23.4M 0.25% 160
2013
Q3 		$2.14M Buy
+47,791
New +$2.12M 0.03% 416

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Winton Capital Management's ABBV Position: Q1 2014 in Review

Winton Capital Management increased its AbbVie (ABBV) stake by 106% in Q1 2014, buying an estimated $27.9M and bringing the position to 1,076,653 shares worth $55.3M. The position accounts for 0.38% of the portfolio, ranked #80.

Winton Capital Management first reported a position in ABBV in Q3 2013 and has held it in 3 quarters since. 1,422 funds tracked by Wall St. Rank hold ABBV as of Q1 2014.

  • Winton Capital Management held 1,076,653 shares of AbbVie worth $55.3M as of Q1 2014.
  • Winton Capital Management bought 552,808 AbbVie shares in Q1 2014, an estimated $27.9M.
  • AbbVie made up 0.38% of Winton Capital Management's portfolio in Q1 2014, its #80 holding.
  • Winton Capital Management first reported a position in AbbVie in Q3 2013 and has held it in 3 quarters since.
  • 1,422 funds tracked by Wall St. Rank held AbbVie as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.